| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/21/2004 | EP1408911A1 Sustained-release therapeutic bioadhesive systems |
| 04/21/2004 | EP1408909A2 Improved conditionally replicating vectors for inhibiting viral infections |
| 04/21/2004 | EP1320525B1 Antibacterial mutilins |
| 04/21/2004 | EP1296946B1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/21/2004 | EP1212331B1 28-epirapalogs |
| 04/21/2004 | EP1196159B1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/21/2004 | EP1187828B1 Quinoline derivatives as antibacterials |
| 04/21/2004 | EP1149094B1 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 04/21/2004 | EP1133496B1 Crystal modification a of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro- 4-oxo-3- quinoline carboxylic acid |
| 04/21/2004 | EP1121099B1 Pharmaceutical composition with gastric residence and controlled release |
| 04/21/2004 | EP1112074B1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 04/21/2004 | EP1105370B1 Novel aryl sulphonamides and analogues |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |
| 04/21/2004 | EP0973750B1 Substituted benzimidazoles and their use for treating retroviral infection |
| 04/21/2004 | EP0939654B1 Use of no syntase inhibitors with scavengers of oxygen reactive forms for the treatment of ischemia |
| 04/21/2004 | EP0859847B1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/21/2004 | EP0857068B1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 04/21/2004 | EP0856007B1 Cyclopeptide derivatives |
| 04/21/2004 | EP0836647B1 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/21/2004 | EP0746327B1 Acidified nitrite as an antimicrobial agent |
| 04/21/2004 | CN1491206A Malic acid addition salts of terbinafine |
| 04/21/2004 | CN1491116A Hepatitis B virus treatment |
| 04/21/2004 | CN1491111A Antiviral method of use |
| 04/21/2004 | CN1491108A Antifungal remedy formulation for external application |
| 04/21/2004 | CN1490409A Preparing method for recombinant chBJSTWO protein and use thereof |
| 04/21/2004 | CN1490322A Ansi glycoside compound and its medicinal composition, preparation and use |
| 04/21/2004 | CN1490308A Acylhydrazone compound, preparing method and use thereof |
| 04/21/2004 | CN1490053A Selection and production of inactivated vaccine Lu8 line of hepatitis A |
| 04/21/2004 | CN1490052A Recombined fowl pox living carrier vaccine for co-expression of MIV-1CNB and hlL-6 proteins |
| 04/21/2004 | CN1490050A Hepatitis A inactivated vaccine |
| 04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
| 04/21/2004 | CN1490048A Method for improving oral drug living thing availability, composition and reagent box |
| 04/21/2004 | CN1490041A Cottonrose hibiscus leaf and magnolia bark containing medicines against catch-cold and preparation thereof |
| 04/21/2004 | CN1490016A Bougie for treating virus hepatitis and preparing method thereof |
| 04/21/2004 | CN1490010A Methanesul fonic pazuthacin injection and its preparing process against infection |
| 04/21/2004 | CN1490005A Berberine or berberine salts drops and their preparation |
| 04/21/2004 | CN1490004A Freeze-dried tinidazole preparation and preparing method thereof |
| 04/21/2004 | CN1490003A Treatment of oral lichen planus |
| 04/21/2004 | CN1490001A Hepadestal drops and preparation thereof |
| 04/21/2004 | CN1146573C Novel arabinosyladenine derivatives |
| 04/21/2004 | CN1146564C Antibiotic sultam and sultone drived oxazolidiones |
| 04/21/2004 | CN1146545C Benzoylpyridazines |
| 04/21/2004 | CN1146541C Beta-alanine derivatives |
| 04/21/2004 | CN1146444C Vaccine composition comprising polysaccharide conjugate antigen and adsorbed onto aluminium phosphate |
| 04/21/2004 | CN1146443C Use of Newcastle virus in preparation of vaccin for intra-ovular immuno-inoculation |
| 04/21/2004 | CN1146425C Application of peimin A in preparing medicine to treat drug-resistant bacterial infective diseases |
| 04/21/2004 | CN1146419C Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 04/20/2004 | US6723755 Method of treating rosacea |
| 04/20/2004 | US6723749 Treating bacterial infections |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723728 Polymorphic and other crystalline forms cis-FTC |
| 04/20/2004 | US6723716 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof |
| 04/20/2004 | US6723695 Cytotoxic epstein-barr virus (ebv) t-cell epitopes derived from ebv structural antigens; vaccines |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723340 Optimal polymer mixtures for gastric retentive tablets |
| 04/20/2004 | US6723328 A homogenized, killed pure microsporum canis culture provided in a carrier wherein the culture is isolated by filtration. |
| 04/20/2004 | US6723327 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 04/20/2004 | US6723326 Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
| 04/20/2004 | US6723325 Attenuated vaccinia viruses that can be used in vaccination methods against variola virus |
| 04/20/2004 | US6723324 Chicken anaemia viruses of low pathogenicity |
| 04/20/2004 | US6723323 Vibrio Cholerae vaccine candidates and method of their constructing |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | CA2300382C New psoralens for pathogen inactivation |
| 04/20/2004 | CA2248182C Porcine reproductive and respiratory syndrome vaccine |
| 04/20/2004 | CA2140238C Antiviral combinations |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031380A1 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 04/15/2004 | WO2004031356A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/15/2004 | WO2004031236A2 Therapeutic uspa1-derived peptides |
| 04/15/2004 | WO2004031226A1 Immunogenic library of chimeric peptides mimicking the genetic diversity of the hypervariable region v3 of the protein of the envelope of a virus gp 120 of human immunodeficiency |
| 04/15/2004 | WO2004031212A1 Antigenic peptides |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | WO2004031195A1 Tricyclic tetrahydroquinoline antibacterial agents |
| 04/15/2004 | WO2004031169A1 Antibacterial agent having thiophene skeleton |
| 04/15/2004 | WO2004031158A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 04/15/2004 | WO2004031157A1 Antibacterial having pyrazole skeleton |
| 04/15/2004 | WO2004030677A1 Compositions comprising highly purified amphotericin b |
| 04/15/2004 | WO2004030673A1 Antibacterial medicinal composition of enhanced oral absorptivity |
| 04/15/2004 | WO2004030670A1 Potent inhibitor of hcv serine protease |
| 04/15/2004 | WO2004017962A3 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004011486A3 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/15/2004 | WO2004005309A3 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/15/2004 | WO2004003545A9 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 04/15/2004 | WO2003103588A3 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003082392A3 Oxygenating agents for enhancing host responses to microbial infections |
| 04/15/2004 | WO2003068807A3 Echinocandin cyclic peptide derivatives |
| 04/15/2004 | WO2003068151A3 Human antibodies for therapy against vaccinia or smallpox |
| 04/15/2004 | WO2003066807A3 Method of inhibiting pathogenicity of infectious agents |
| 04/15/2004 | WO2003066064A3 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 04/15/2004 | WO2003043580A3 Methods for identifying and validating potential drug targets |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2003008571A9 Chimeric chains that code for proteins that induce effects directed against viruses |
| 04/15/2004 | WO2002102975A3 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 04/15/2004 | WO2002062361A8 Antiviral composition containing propolis and essential oils |
| 04/15/2004 | WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |